Biotest AG VZ Stock
Your prediction
Pros and Cons of Biotest AG VZ in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Biotest AG VZ vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Biotest AG VZ | - | - | - | - | - | - | - |
| MPH Health Care AG | -2.580% | -7.767% | -12.844% | -14.414% | -13.242% | 32.867% | -26.641% |
| Pacira Pharmaceuticals | 0.000% | 8.511% | 11.475% | 3.030% | -5.556% | -43.017% | -66.000% |
| Rockwell Medical Inc. | 0.130% | 3.634% | -9.091% | -48.803% | 13.821% | -41.667% | -93.694% |
News
EQS-News: Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt)
EQS-News: Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt)
EQS-News: Biotest obtains approval for new human fibrinogen Prufibry® in Germany
EQS-News: Biotest obtains approval for new human fibrinogen Prufibry® in Germany
EQS-News: Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A.
EQS-News: Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A.